Cecile Sigoillot-Claude

Title: Cecile Sigoillot-Claude: Innovator in Veterinary Medicine

Introduction

Cecile Sigoillot-Claude is a prominent inventor based in Ouillins, France. She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for treating heartworm infestations in mammals. Her innovative approach combines genetic engineering with immunology to create effective solutions for animal health.

Latest Patents

Cecile holds a patent for a heartworm vaccine, titled "Heartworm vaccine, methods and uses thereof." This invention encompasses a vaccine composition designed to treat heartworm infestation in mammals. The vaccine includes chimeric antigens engineered using the genetic code of the target sequence. Upon introduction into the host, such as a canine, the vaccine prompts the host to generate antibodies. These antibodies circulate in the host's plasma and are consumed by heartworm larvae, effectively targeting the internal antigens of the worm.

Career Highlights

Cecile Sigoillot-Claude is associated with Boehringer Ingelheim Animal Health USA Inc., where she continues to advance her research and development efforts. Her work has been instrumental in improving the health and well-being of pets and other mammals affected by heartworm.

Collaborations

Cecile collaborates with notable colleagues, including Laurent Bernard Fischer and Yovany Moreno. Their combined expertise enhances the research and development processes within their organization.

Conclusion

Cecile Sigoillot-Claude's innovative contributions to veterinary medicine, particularly through her heartworm vaccine, demonstrate her commitment to improving animal health. Her work not only benefits individual animals but also contributes to the broader field of veterinary science.